UBE (4208) Corporate presentation summary

Vision and strategic direction

• Aims to transform into a specialty chemicals company contributing to the global environment, human health, and an enriched society by 2030, guided by the slogan "Breaking Through with the Chemistry of Hope."

• Six-year action plan (FY2025–2030) focuses on expanding specialty businesses, empowering a diverse workforce, and addressing global environmental issues.

• Targets include upholding integrity in governance, ensuring safety, and advancing sustainability management.

Growth strategy and business portfolio

• Major investments in C1 chemicals (urethane systems, DMC, EMC) and polyimide chain (films, separation membranes) to drive specialty business growth.

• Restructuring and scaling down basic businesses (ammonia, caprolactam, nylon polymers) in Thailand and Japan to reduce earnings volatility.

• Public listing planned for machinery and cement-related businesses to support independence and capital efficiency.

• Strategic M&A and R&D to acquire new businesses adjacent to existing strengths.

Financial and operational targets

• FY2030 targets: net sales ¥550–555 billion, EBITDA ¥100 billion+, ROS 10%+, ROE 8%+, ROIC 6%+.

• DOE (dividend on equity) to rise from 2.5% to 3.5% in FY2026, aiming for 4.0% at the earliest opportunity.

• Cash allocation balances growth investment, shareholder returns, and debt repayment, with a focus on maintaining a D/E ratio around 0.6.